Skip to main content
. 2017 Sep 7;1:29. doi: 10.1038/s41698-017-0036-8

Fig. 2.

Fig. 2

Axial T2 FLAIR image of the thalamic tumor pre-radiation (left), post-radiation (November 2016, center) and after two cycles of ponatinib (March 2017, right). Dimensions of the post-radiation tumor are 45.6 mm × 28.6 mm × 35.0 mm compared to 40.3 mm × 26.6 mm 36.0 mm after two cycles on ponatinib. This represents a 15% reduction in volume